Skip to main content

What the FDA labels say about taking them together

Alprazolam and erythromycin

Alprazolam's FDA label of January 18, 2023 names erythromycin in its drug interactions section, and erythromycin's label names alprazolam too. The erythromycin label: “Triazolobenzodiazepines and related benzodiazepines Erythromycin has been reported to decrease the clearance of triazolam and midazolam, and thus, may increase the pharmacologic effect of these benzodiazepines.”

Check it at the source: the alprazolam FDA label on DailyMed (effective January 18, 2023, PHARMACIA & UPJOHN COMPANY LLC); the erythromycin FDA label on DailyMed (effective August 1, 2024, Teva Pharmaceuticals USA, Inc.).

What does the alprazolam label say about erythromycin?

Alprazolam label, drug interactions

Examples; Nefazodone, fluvoxamine, cimetidine, erythromycin

Source: FDA drug label (Xanax), PHARMACIA & UPJOHN COMPANY LLC, effective January 18, 2023 (SPL set 388e249d-b9b6-44c3-9f8f-880eced0239f), via openFDA; the full label on DailyMed

What does the erythromycin label say about alprazolam?

Erythromycin label, drug interactions

Triazolobenzodiazepines (such as triazolam and alprazolam) and related benzodiazepines Erythromycin has been reported to decrease the clearance of triazolam and midazolam, and thus, may increase the pharmacologic effect of these benzodiazepines.

Source: FDA drug label (Erythromycin), Teva Pharmaceuticals USA, Inc., effective August 1, 2024 (SPL set 75a0bd5a-d09f-483b-bfd8-f8343b149eb2), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

30Alprazolam generic labelers
38Erythromycin generic labelers
AlprazolamErythromycin
Labeled forAnxietyBacterial infections, Acne
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0236 per tablet 0.25 mg tablet$1.96 per tablet 250 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?